Rokit Healthcare

Beta

KRX Filings & Disclosures 2026

Management Discussion & Analysis

• • No specific financial figures disclosed for FY2025 revenue, operating profit, or net income in the MD&A section
• • No segment-level performance attribution or key business driver described for FY2025 in the management narrative

Risk Factors

• • USD foreign exchange exposure sensitivity ±KRW 464M pre-tax for 10% KRW/USD fluctuation at FY2025 year-end
• • Interest-bearing debt with variable rate KRW 2.88B; 1% interest rate change impacts profit/loss by ±KRW 28.8M

Business Overview

• • AI personalized long-term regeneration platform combining 3D bioprinter, disposable medical kits, and bioink for chronic wounds, cartilage, kidney regeneration, FY2025
• • Dr. INVIVO AI Regen Kit received MFDS Class 3 approval Jan 2023, USFDA Class I/II registration Feb 2023, and EU CE MDR Class IIa July 2023

What are the latest Rokit Healthcare DART filings in 2026?

Rokit Healthcare (KRX code 376900) has filed an annual report on March 23, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Rokit Healthcare file its most recent annual report?

Rokit Healthcare filed its most recent annual report on March 23, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Rokit Healthcare's KRX stock code?

Rokit Healthcare's KRX stock code is 376900. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 376900 to look up all Rokit Healthcare disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Rokit Healthcare file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Rokit Healthcare.

Where can I find Rokit Healthcare financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Rokit Healthcare annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.